Publications by authors named "Fanya Sun"
Article Synopsis
- A network meta-analysis was conducted to compare the effectiveness of recent Alzheimer's disease drugs based on data from randomized controlled trials published between 2020 and 2024.
- The analysis found GV-971 and Lecanemab to be particularly effective in improving specific cognitive assessments, with Donanemab showing promise for slowing functional decline.
- Overall, GV-971 was identified as the top drug for cognitive improvement, while Donanemab and Lecanemab demonstrated significant efficacy in other areas of Alzheimer's treatment.
Rationale: Myelin oligodendrocyte glycoprotein (MOG) antibody-related disease is a relatively recent entity in inflammatory demyelinating disease. Its clinical presentation varies in severity and the lack of specific imaging features makes it easy to misdiagnose. We now report the case of a MOG antibody-positive patient who presented with diplopia and dizziness, and whose brain magnetic resonance imaging (MRI) showed abnormal signals in the bilateral pontine brachium.
View Article and Find Full Text PDF